RECORDATI RARE DISEASES INC.

Lobbying client · New Jersey · filed 2025 to 2026

Pharmaceutical manufacturer of treatments for rare and ultra-rare diseases.

$180,000 Reported spend

4 Filings counted

1 Firms hired

0 Bills named

Spend is reported income plus in-house expenses across 4 filings. Everything on this page is grouped by the client's LDA id (69790), not by name.

Firms hired 1

ARNOLD & PORTER KAYE SCHOLER LLP $180,000 4 filings

Reported by year 2 years

2026 $120,000 2 filings
2025 $60,000 2 filings

Issues lobbied 3

The count is how many filings named that issue area. A filing reports one lump figure covering every issue on it, so the money above cannot be split between them.

Agencies and chambers lobbied 2

HOUSE OF REPRESENTATIVES 2
SENATE 2

Recent filings 4 total

Q2

ARNOLD & PORTER KAYE SCHOLER LLP

2nd Quarter (Apr 1 - June 30) 2026 · $60,000 income · posted Jul 17, 2026

View → Q1

ARNOLD & PORTER KAYE SCHOLER LLP

1st Quarter (Jan 1 - Mar 31) 2026 · House · Senate · $60,000 income · posted Apr 17, 2026

View → Q4

ARNOLD & PORTER KAYE SCHOLER LLP

4th Quarter (Oct 1 - Dec 31) 2025 · House · Senate · $60,000 income · posted Jan 14, 2026

View → RR

ARNOLD & PORTER KAYE SCHOLER LLP

4th Quarter (Oct 1 - Dec 31) 2025 · posted Nov 14, 2025

View →

Foreign entities disclosed 1

RECORDATI INDUSTRIA CHIMICA E FARMACEUTICA S.P.A. Italy named on 1 filing · highest disclosed ownership 100% · largest disclosed contribution $0

Section 7 of the LD-2: a foreign company or government that owns part of the client, pays toward the lobbying, or benefits from it. Figures are the highest single disclosure across these filings, not a sum: the same stake is re-disclosed each quarter.

Source: federal Lobbying Disclosure Act filings, synced daily. Money is self-reported by the filer and often rounded. Lobbying is legal, disclosed activity.